ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO268

Asymptomatic Heartbeat Irregularities (AHbI) During Hemodialysis (HD) Are Associated with Decreased Short-Term Survival

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis


  • Sapoznikov, Dan, Hadassah University Medical Center, Jerusalem, Israel
  • Backenroth, Rebecca, Hadassah University Medical Center, Jerusalem, Israel
  • Dranitzki Elhalel, Michal, Hadassah University Medical Center, Jerusalem, Israel
  • Rubinger, Dvora, Hadassah University Medical Center, Jerusalem, Israel

Intradialytic AHbI are not well defined and are of unknown significance.


Beat-to-beat systolic blood pressure (SBP) and interbeat interval (IBI) were monitored during regular HD sessions in 83 age-matched patients (Pt). AHbI were defined as ≥10 irregular beats on a 4hr recording. Hemodynamic variability indices were assessed using Finometer device and Beatscope software .


AHbI were detected in 25 Pt (AHbI (+)). The representative clinical, laboratory and hemodynamic data in AHbI (+) and in Pt with regular beats (AHbI(-)) are listed in Table 1.There were no statistically significant differences between groups regarding the proportion of diabetes, hypertension, ischemic heart disease, SBP, intradialytic hypotension, PTH level or ultrafiltration rate. Kaplan-Meier analysis showed a significnant decreased survival at 2y in AHbI(+) (Figure 1).


1.Intradialytic AHbI are associated with cardiovascular risk factors and a higher plasma phosphate level, suggesting a link between mineral metabolism and heart disease.
2. In AHbI (+), diminished post HD plasma potassium change combined with decreased IBI and increased sdCO suggest a tendency to hemodynamic instability leading to higher mortality.
The nature and the long term effects of the AHbI remain to be further explored.

Table 1.
 AHbI (+) (n=25)
Age 65±9 y
AHbI (-) (n=58)
Age 66±10 y
Male gender (n)22340.009
History of smoking (n,%)17 (68)19 (33)0.003
Left ventricular systolic dysfunction (n,%)13 (54)13 (24)0.008
Peripheral vascular disease (n,%)18 (72)28 (48)0.046
Plasma calcium (mmo/L)* ^2.25±0.172.27±0.17NS
Plasma phosphate (mmol/L)* ^1.69±0.371.46±0.310.004
Plasma potassium decrease after HD (mmol/L)^1.24±0.561.54±0.610.039
IBI (msec)**839 (122)891 (234)0.010
sdDBP (mmHg)^^ **3.7 (0.9)2.9 (1.3)0.003
sdCO (L/min)^^ **0.57 (0.25)0.44 (0.21)0.001

* Predialysis: ^mean±SD; **Median (interquartile range); ^^ sd (standard deviation) ; DBP: diastolic blood pressure; CO: cardiac output.

Figure 1.